Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-11 4:34 pm Purchase |
2025-03-31 | 13G | Talphera, Inc. TLPH |
Rosalind Advisors, Inc. | 7,642,515 9.900% |
7,642,515 (New Position) |
Filing History |
| 2025-04-03 5:30 pm Unchanged |
2025-03-31 | 13D | Talphera, Inc. TLPH |
Nantahala Capital Management, LLC | 1,992,519 11.700% |
0 (Unchanged) |
Filing History |
| 2025-04-02 9:59 pm Unchanged |
2025-03-31 | 13D | Talphera, Inc. TLPH |
Nantahala Capital Management, LLC | 1,992,519 11.700% |
0 (Unchanged) |
Filing History |
| 2024-02-14 2:58 pm Purchase |
2023-12-31 | 13G | Talphera, Inc. TLPH |
Armistice Capital, LLC | 890,346 4.990% |
26,018 (+3.01%) |
Filing History |
| 2024-02-13 8:00 pm Sale |
2023-12-31 | 13G | Talphera, Inc. TLPH |
Lind Global Fund II LP | 735,296 4.200% |
-367,648 (-33.33%) |
Filing |
| 2024-01-22 6:46 pm Purchase |
2024-01-17 | 13D | Talphera, Inc. TLPH |
Nantahala Capital Management, LLC | 1,992,519 11.800% |
1,992,519 (New Position) |
Filing History |
| 2023-07-31 7:50 pm Purchase |
2023-07-20 | 13G | Talphera, Inc. TLPH |
Lind Global Fund II LP | 1,102,944 6.500% |
1,102,944 (New Position) |
Filing History |
| 2023-02-14 11:50 am Purchase |
2022-12-31 | 13G | Talphera, Inc. TLPH |
Armistice Capital, LLC | 864,328 9.990% |
864,328 (New Position) |
Filing History |
| 2022-02-14 6:43 pm Purchase |
2021-12-31 | 13G | AcelRx Pharmaceuticals, Inc. ACRX |
Armistice Capital, LLC | 615,724 9.990% |
615,724 (New Position) |
Filing History |
| 2022-01-27 2:51 pm Sale |
2022-01-27 | 13G | AcelRx Pharmaceuticals, Inc. ACRX |
BML Investment Partners, L.P. | 0 0.000% |
-297,800 (Position Closed) |
Filing History |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | AcelRx Pharmaceuticals, Inc. ACRX |
BLACKROCK INC BLK |
113,302 1.900% |
-168,745 (-59.83%) |
Filing History |
| 2021-02-10 2:58 pm Purchase |
2021-02-10 | 13G | AcelRx Pharmaceuticals, Inc. ACRX |
BML Investment Partners, L.P. | 297,800 6.000% |
59,910 (+25.18%) |
Filing History |
| 2021-01-28 5:55 pm Purchase |
2020-12-31 | 13G | AcelRx Pharmaceuticals, Inc. ACRX |
BLACKROCK INC BLK |
282,047 5.700% |
1,446 (+0.52%) |
Filing History |
| 2020-10-27 4:04 pm Unchanged |
2020-10-09 | 13G | AcelRx Pharmaceuticals, Inc. ACRX |
BML Investment Partners, L.P. | 237,890 5.300% |
0 (Unchanged) |
Filing History |
| 2020-10-27 3:50 pm Purchase |
2020-10-09 | 13G | AcelRx Pharmaceuticals, Inc. ACRX |
BML Investment Partners, L.P. | 237,890 5.300% |
237,890 (New Position) |
Filing History |